:::

學術成果

:::
搜尋
年至

月至


  • 關鍵字搜尋
  • 期刊論文
    學年度著作著作人
    98Dore DD, Seeger JD, Chan KA. ,2009,Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. ,Current Medical Research and Opinion,25,4,pp1019-1027 (SCI)陳建煒
    98Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. ,2009,Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. ,Pharmacoepidemiology and Drug Safety,18,3,pp226-234 (SCI)陳建煒
    98Platt R, Wilson M, Chan KA, Benner JS, Janet Marchibroda J, McClellan M. ,2009,The New Sentinel Network - Improving the Evidence of Medical-Product Safety. ,New England Journal of Medicine,361,pp645-647 (SCI)陳建煒
    97Gainford MC, Yang CH, Liu MY et al.,2009,Translation and cultural adaptation of the patient disease and treatment assessment form. A novel quality of life instrument for use in Taiwan.,Asia Pacific Journal of Clin Oncology,4,3,pp149-156 (SCI)楊志新
    97Wu JU, Yu CJ, Yang CH, Wu SG, Chiu YH, Gow CH, Chang YC, Hsu YC, Wei PF, Shih JY, Yang PC.,2008,First or second-line therapy with gefitinib produces equal survival in non small cell lung cancer. ,Am J Respir Crit Care Med. ,178,8,pp847-853 (SCI)楊志新
    97Wu SG, Gow CH, Yu CJ, Chang YL, Yang CH, Hsu YC, Shih JY, Lee YC, Yang PC.,2008,Frequent EGFR mutations in malignant pleural effusion of lung adenocarcinoma.,Eur Respir J. ,32,4,pp924-930 (SCI)楊志新
    97Perng RP, Yang CH*, Chen YM, Chang GC, Lin gMC, Hsieh RK, Chu NM, Lai RS, Su WC, Tsa CJ, Hsia TC, Chen HC, Chen CH, Huang MS, Wang JL, Ho ML, Chung CY, Yu CJ, Chang WC, Kou HP, Yu CT, Lin ZZ, Kao WY.,2008,High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy.,Lung Cancer ,62,1,pp78-84 (SCI)楊志新
    97Perng RP, Yang CH*, Chen YM, Chang GC, Lin gMC, Hsieh RK, Chu NM, Lai RS, Su WC, Tsa CJ, Hsia TC, Chen HC, Chen CH, Huang MS, Wang JL, Ho ML, Chung CY, Yu CJ, Chang WC, Kou HP, Yu CT, Lin ZZ, Kao WY.,2008,High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy.,Lung Cancer ,62,1,pp78-84 (SCI)楊志新
    97Wu JY, WuSG, Yang CH, Gow CH, Chang YL, Yu CJ, Shih JY, Yang PC.,2008,Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response. ,Clinical Cancer Research,14,15,pp4877-4882 (SCI)楊志新
    97Lin ZZ, Hsu C, Chang YC, Yu CJ, Hsu CH, Lin CC, Cheng AL, Yang PC and Yang CH*,2008,Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.,Lung Cancer,60,2,pp215-221 (SCI)楊志新